Cinryze NDC:42227-0083-01

Ended Awarded

Contract number
36C26124N0850
Awardee
Awarding agency
Obligated
$63,937

Award facts

Contract value 100% obligated
$63,936.90 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Lexington, MA 02421, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company Limited, a global biopharmaceutical firm. The $63,936.90 award is for the medication CINRYZE (NDC: 42227-0083-01) and was made under Takeda's Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The delivery order has an ultimate completion date of September 19, 2024. Takeda Pharmaceuticals America Inc. is the prime contractor, and no set-aside designation was used for this award. This order supports the VA's procurement of specialized pharmaceutical products, including treatments for rare diseases, hematology, immunology, and oncology. Takeda also holds a $19,472,334.90 Blanket Purchase Agreement (BPA) with the VA National Acquisition Center, awarded in 2020, to facilitate streamlined ordering of critical specialty pharmaceuticals for the VA healthcare system.

Quick answers

Who was awarded contract 36C26124N0850?

36C26124N0850 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on August 19, 2024.

How much is contract 36C26124N0850 worth?

The government has obligated $63,937 on 36C26124N0850.

Is contract 36C26124N0850 an order under another contract?

Yes. 36C26124N0850 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26124N0850 competed?

The extent of competition for 36C26124N0850 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award